RxDoctor Payments Data

Claudia Lucas

Acute Care · Phoenix, AZNPI 1790203867

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.7% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Medtronic at 41.4% of the total. Among acute care clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,562in general payments, 2019–2025

Across 101 payments — averaging $45.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Edwards Lifesciences$652
  • Boston Scientific$567
  • Abiomed$319
  • AstraZeneca$185
  • Novartis$148
  • plus $804 from 11 others

What the payments were for

  • Food & beverage$4,549100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,562 in reported general payments places this provider in the 90th percentile of 482 acute care providers in Arizona.

See all acute care providers in Arizona

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban56$55,931
EliquisApixaban44$54,895
EntrestoSacubitril/Valsartan24$29,153
Digoxin14$1,582
SotalolSotalol Hcl46$631
Flecainide Acetate13$333
Carvedilol55$298
Metoprolol Succinate29$292
Lisinopril16$149
Amiodarone Hcl20$84
Losartan Potassium23$84
Cephalexin19$62

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$120$55,93156 claims
NovartisEntresto$148$29,15324 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 482 acute care providers in Arizona.

Other acute care in Phoenix

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →